Eric Lefkofsky is a famous and renowned entrepreneur who recently founded Tempus. Tempus is a startup for cancer-fighting. Tempus specifically designed for medical practitioners and experts from the Chicago University to help others by searching better cure and treating breast cancer with advanced technology and methods.
Tempus, a Chicago-based company, recently announced a partnership with the Medicine department of Chicago University this Thursday to provide molecular analysis and sequencing to breast cancer specialists. This partnership is formed to make personalized plans for different patients according to their available funding, their priorities and what they want to do.
Experts at Tempus are working hard to properly analyze data before a huge number of the individual across the globe who are suffering from such life-threatening diseases so that they can learn the progress and to help researchers and doctors to uncover the patterns which can predict how the sick individual is going to respond to such treatment.
The goal for Tempus is that to provide a central database that everyone can use to save the time which would otherwise get wasted when a scientist is repeating the same experiment again and again from a different part of the world. Like if a scientist is doing experiments in America then he will update his finding on Tempus so that another scientist who is working on same cure can know that such process has already done and that was the finding so that he can skip repeating same procedure and proceed to next step. Click here to know more.
- OlufunmilayoOlopade once said to the media that although cancer of the breast is the diseases that millions of patients across the globe are suffering from it, there’s comparatively very little data available about those patients who’ve battled or still battling with that disease. And this was the reason of founding Tempus so that there would a centralized database would be available online so that anyone who wants can get access to it to collect the information that they need. That will not just help them to save time which otherwise gets wasted in the repetition of same procedures but also scientists to proceed toward the cure with more rapid pace.